This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Angel yeast: it is expected that the rise of community e-commerce will not have an adverse impact on the company's main business
Gan&Lee Pharmaceuticals's Insulin New Factory Completed in Brazil
EqualOcean has learned that Gan&Lee Pharmaceuticals(甘李药业) has made significant progress in its insulin production cooperation with the Brazilian local enterprise Biomm S.A. (hereinafter referred to as Biomm), signaling the official completion of the insulin new factory in Brazil. This signifies a significant achievement in Gan&Lee Pharmaceuticals's strategic deployment in overseas markets, including Brazil.
May 15, 2024 04:53 PM
Where to go: December 31 or meet the small peak of travel, and travel on New Year's Day is mainly short-distance travel
Zhengbang Technology: the controlling shareholder pledged 5.66 million shares
CSC: the benefits of condiment price increase will be more reflected in next year